Navigation Links
XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Date:8/19/2007

shares Amount capital

----------- ------- -------

BALANCE AT DECEMBER 31, 2006 220,124,349 1,072 136,611

CHANGES DURING THE SIX MONTHS

ENDED JUNE 30, 2007:

Comprehensive loss - loss for

the period -- -- --

Non-employee stock option

compensation expenses -- -- 5

Employee stock option compensation

expenses -- -- 964

Exercise of stock options 30,000 (**) 3

----------- ------- --------

BALANCE AT JUNE 30, 2007 220,154,349 1,072 137,583

=========== ======= ========

Deficit

accumulated

during the

development

stage Total

--------- ---------

BALANCE AT DECEMBER 31, 2006 (114,923) 22,760

CHANGES DURING THE SIX MONTHS

ENDED JUNE 30, 2007:

Comprehensive loss - loss for the

period (14,649) (14,649)

Non-employee stock option

compensation expenses -- 5

Employee stock option compensation

expenses -- 964

Exercise of stock options -- 3

--------- ---------

BALANCE AT JUNE 30, 2007 (129,572) 9,083

========= =========

(**) Represents an amount less than $1,000.

<
'/>"/>
SOURCE XTL Biopharmaceuticals Ltd

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... 28, 2015 , ... Riordan-McKenna Institute founders, stem ... that the use of sterile, dehydrated amniotic tissue AlphaPATCH™ developed by Amniotic ... surgical knee wound. , The case involved a 78-year-old male, who presented with ...
(Date:8/27/2015)... ... , ... Capital Edge Consulting , a nationwide consulting firm that specializes ... ranking as one of the top 5000 companies listed on the 2015 Inc. ... , “It is truly an honor to be recognized as one of America’s fastest ...
(Date:8/27/2015)... , Aug. 27, 2015 The ... a patient,s eyes—and life—were saved by doctors at Vanderbilt ... working with NNFF, NovaBay Pharmaceuticals and Dr. John ... Center at Seton Medical Center in ... treatment used a breakthrough approach, pioneered by Dr. Crew, ...
(Date:8/27/2015)... HUYA Bioscience International (HUYA) today announced the sponsorship ... of HTLV-1, held this week at the University of ... Society is to promote research on HTLV-1 and HTLV-1-associated ... and research related to these fields to advance science, ... proud to support this prestigious conference," said Mireille ...
Breaking Biology Technology:Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4
... Jayne Garno, LSU associate professor of chemistry in the ... government,s highest honor for scientists and engineers in the ... Early Career Award for Scientists and Engineers, or PECASE. ... a prestigious award. LSU is a rich environment for ...
... DIEGO, Nov. 10, 2010 Anadys Pharmaceuticals, Inc. (Nasdaq: ... the Lazard 7th Annual Healthcare Conference on Wednesday, November 17, ... is being held at the St. Regis New York.  Steve ... provide an overview of Anadys and its clinical development programs. ...
... Dendreon Corporation (Nasdaq: DNDN ) today ... the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics ... manufacturing facility. Dendreon is requesting licensure for an ... U.S. Food and Drug Administration (FDA) review for ...
Cached Biology Technology:LSU’s Jayne Garno receives early career award from President 2Anadys Pharmaceuticals to Present at the Lazard Healthcare Conference 2Dendreon Submits Post-Approval Supplement to the PROVENGE Biologics License Application for New Jersey Manufacturing Facility 2
(Date:8/12/2015)... MINNETONKA, Minn. , Aug. 12, 2015   ... that supports the entire spectrum of clinical research, is ... ™ , the company,s comprehensive SaaS-based eClinical technology platform, ... growth during the first two quarters of 2015.   ... and second largest quarters measured by contract value sold ...
(Date:8/11/2015)... Today, ZUK announced its Android smartphone Z1, featuring FPC,s touch ... 2015 that relate to sales of FPC1155 for this smartphone model ... for 2015. Jörgen Lantto, CEO of FPC, comments: " ... manufacturer in China and we are proud ... for Z1 , its first ...
(Date:8/6/2015)... BOSTON and TELTOW, Germany ... the 2015 Siggraph Conference, SensoMotoric Instruments (SMI) ... augmented reality , based on Epson,s Moverio ... eye tracking platform. With this new solution, unprecedented quality ... multi-modal, hands-free interaction with context-sensitive displays. For the first ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... , Sept. 30, 2013 /PRNewswire-iReach/ -- Clinilabs, a ... drug development services to industry, announced today that they ... an investigational medication for Type 2 Diabetes Mellitus.  The ... tolerability of multiple daily doses of the investigational medication ...
... chemical engineering researchers have created a new synthetic metabolic pathway ... percent increase in the production of biofuels. ... pathway known as glycolysis, a series of chemical reactions that ... precursors that cells need. Glycolysis converts four of the six ...
... has detected propylene, a chemical used to make food-storage ... moon Titan. This is the first definitive detection ... other than Earth. A small amount of propylene ... Infrared Spectrometer (CIRS). This instrument measures the infrared light, ...
Cached Biology News:Leading Pharma Company Selects Clinilabs to Conduct a Phase 1 Study of an Investigational Type 2 Diabetes Medication 2UCLA engineers develop new metabolic pathway to more efficiently convert sugars into biofuels 2NASA's Cassini spacecraft finds ingredient of household plastic in space 2
Mouse polyclonal antibody raised against a partial recombinant COASY. NCBI Entrez Gene ID = 80347...
... starter kit is intended for first-time users of ... The kit includes a protein sample and reagents ... gels six 17 cm, ten 11 cm, or ... strips and precast SDS-PAGE gels and gels stains ...
... Phosphate Phosphatase 2 (LPP2) ... aqueous solution Solution ... containing 0.08% sodium azide. ... the human LPP2 protein. ...
... Phospho-Specific(Thr 222 ) ... 10 mM sodium HEPES, 100 ... 7.5. Recognizes the ~47 kDa ... (MAPKAPK-2) protein phosphorylated at Thr ...
Biology Products: